Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
11/17/2022 | Acrivon Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 2.2M | $0.00 | $0 | | 11/17/2022 |
11/17/2022 | Acrivon Therapeutics, Inc. | | Conversion | Common Stock | 888.1k | $0.00 | $0 | | 11/17/2022 |
08/02/2021 | Nuvalent, Inc. | | Conversion | Series B Preferred Stock | 4.8M | $0.00 | $0 | | 08/02/2021 |
08/02/2021 | Nuvalent, Inc. | | Conversion | Class A Common Stock | 897.7k | $0.00 | $0 | | 08/02/2021 |
06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Common Stock | 1.2M | $0.00 | $0 | | 06/21/2021 |
06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Series A-2 Preferred Stock | 12.4M | $0.00 | $0 | | 06/21/2021 |
06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 10.7M | $0.00 | $0 | | 06/21/2021 |
06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Common Stock | 1.3M | $0.00 | $0 | | 06/21/2021 |
03/30/2021 | Edgewise Therapeutics, Inc. | | Conversion | Series C Preferred Stock | 681.8k | $0.00 | $0 | | 03/30/2021 |
03/30/2021 | Edgewise Therapeutics, Inc. | | Conversion | Common Stock | 681.8k | $0.00 | $0 | | 03/30/2021 |
11/23/2020 | Olema Pharmaceuticals, Inc. | OLMA | Conversion | Common Stock | 1.3M | $0.00 | $0 | | 11/23/2020 |
11/23/2020 | Olema Pharmaceuticals, Inc. | OLMA | Conversion | Common Stock | 452k | $0.00 | $0 | | 11/23/2020 |
11/23/2020 | Olema Pharmaceuticals, Inc. | OLMA | Conversion | Series B Preferred Stock | 1.3M | $0.00 | $0 | | 11/23/2020 |
11/23/2020 | Olema Pharmaceuticals, Inc. | OLMA | Conversion | Series C Preferred Stock | 452k | $0.00 | $0 | | 11/23/2020 |
10/20/2020 | Aligos Therapeutics, Inc. | ALGS | Conversion | Series B-2 convertible Preferred Stock | 571.1k | $0.00 | $0 | | 10/20/2020 |
10/20/2020 | Aligos Therapeutics, Inc. | ALGS | Conversion | Series B-1 convertible Preferred Stock | 1.3M | $0.00 | $0 | | 10/20/2020 |
10/20/2020 | Aligos Therapeutics, Inc. | ALGS | Conversion | Common Stock | 571.1k | $0.00 | $0 | | 10/20/2020 |
10/20/2020 | Aligos Therapeutics, Inc. | ALGS | Conversion | Common Stock | 1.3M | $0.00 | $0 | | 10/20/2020 |
09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Common Stock | 760.3k | $0.00 | $0 | | 09/29/2020 |
09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Series D Preferred Stock | 760.3k | $0.00 | $0 | | 09/29/2020 |
09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Common Stock | 1.6M | $0.00 | $0 | | 09/21/2020 |
09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 5.3M | $0.00 | $0 | | 09/21/2020 |
08/25/2020 | Kymera Therapeutics, Inc. | | Conversion | Common Stock | 959.2k | $0.00 | $0 | | 08/25/2020 |
08/25/2020 | Kymera Therapeutics, Inc. | | Conversion | Series C Preferred Stock | 1.5M | $0.00 | $0 | | 08/25/2020 |
07/28/2020 | Nurix Therapeutics, Inc. | NRIX | Conversion | Common Stock | 784.3k | $0.00 | $0 | | 07/28/2020 |
07/28/2020 | Nurix Therapeutics, Inc. | NRIX | Conversion | Series D Preferred Stock | 784.3k | $0.00 | $0 | | 07/28/2020 |
06/23/2020 | Forma Therapeutics Holdings, Inc. | FMTX | Conversion | Series D Convertible Preferred Stock | 5.4M | $0.00 | $0 | | 06/23/2020 |
06/23/2020 | Forma Therapeutics Holdings, Inc. | FMTX | Purchase | Common Stock | 1000k | $20.00 | $20M | | 06/23/2020 |
06/23/2020 | Forma Therapeutics Holdings, Inc. | FMTX | Conversion | Common Stock | 1.3M | $0.00 | $0 | | 06/23/2020 |
06/16/2020 | Generation Bio Co. | GBIO | Conversion | Series C Preferred Stock | 1.8M | $0.00 | $0 | | 06/16/2020 |
06/16/2020 | Generation Bio Co. | GBIO | Purchase | Common Stock | 1.1M | $19.00 | $20.9M | | 06/16/2020 |
06/16/2020 | Generation Bio Co. | GBIO | Conversion | Common Stock | 1M | $0.00 | $0 | | 06/16/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Common Stock | 568.2k | $0.00 | $0 | | 02/03/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Series C Preferred Stock | 1.7M | $0.00 | $0 | | 02/03/2020 |